Migueles Stephen A, Osborne Christine M, Royce Cassandra, Compton Alex A, Joshi Rohan P, Weeks Kristin A, Rood Julia E, Berkley Amy M, Sacha Jonah B, Cogliano-Shutta Nancy A, Lloyd Margaret, Roby Gregg, Kwan Richard, McLaughlin Mary, Stallings Sara, Rehm Catherine, O'Shea Marie A, Mican JoAnn, Packard Beverly Z, Komoriya Akira, Palmer Sarah, Wiegand Ann P, Maldarelli Frank, Coffin John M, Mellors John W, Hallahan Claire W, Follman Dean A, Connors Mark
National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Immunity. 2008 Dec 19;29(6):1009-21. doi: 10.1016/j.immuni.2008.10.010. Epub 2008 Dec 8.
Virus-specific CD8+ T cells probably mediate control over HIV replication in rare individuals, termed long-term nonprogressors (LTNPs) or elite controllers. Despite extensive investigation, the mechanisms responsible for this control remain incompletely understood. We observed that HIV-specific CD8+ T cells of LTNPs persisted at higher frequencies than those of treated progressors with equally low amounts of HIV. Measured on a per-cell basis, HIV-specific CD8+ T cells of LTNPs efficiently eliminated primary autologous HIV-infected CD4+ T cells. This function required lytic granule loading of effectors and delivery of granzyme B to target cells. Defective cytotoxicity of progressor effectors could be restored after treatment with phorbol ester and calcium ionophore. These results establish an effector function and mechanism that clearly segregate with immunologic control of HIV. They also demonstrate that lytic granule contents of memory cells are a critical determinant of cytotoxicity that must be induced for maximal per-cell killing capacity.
病毒特异性CD8 + T细胞可能在极少数个体(称为长期不进展者(LTNP)或精英控制者)中介导对HIV复制的控制。尽管进行了广泛研究,但这种控制的机制仍未完全了解。我们观察到,LTNP的HIV特异性CD8 + T细胞以比HIV含量同样低的接受治疗的进展者更高的频率持续存在。以每细胞为基础测量,LTNP的HIV特异性CD8 + T细胞有效地消除了原发性自体HIV感染的CD4 + T细胞。该功能需要效应细胞的溶细胞颗粒装载以及颗粒酶B向靶细胞的递送。在用佛波酯和钙离子载体治疗后,进展者效应细胞的细胞毒性缺陷可以恢复。这些结果建立了一种效应功能和机制,该功能和机制与HIV的免疫控制明显分离。它们还表明,记忆细胞的溶细胞颗粒内容物是细胞毒性的关键决定因素,必须诱导其产生最大的每细胞杀伤能力。
Immunity. 2008-12-19
J Acquir Immune Defic Syndr. 2011-10-1
Front Immunol. 2025-2-25
Curr Opin HIV AIDS. 2025-3-1
Mol Ther Nucleic Acids. 2024-10-28
Immunol Rev. 2024-11
J Immunol. 2007-9-15
Curr Opin Immunol. 2007-6